Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades-Behçet's disease.
Behrens
F
F
Center of Rheumatology, Klinikum der J. W. Goethe-Universität, Frankfurt am Main, Germany.
Zollner
T
T
Moeller
B
B
Kaltwasser
J P
JP
Kaufmann
R
R
Ochsendorf
F R
FR
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D005260:Female; D005858:Germany; D006115:Greece / Q000208:ethnology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha